Certified by Founder Lodge
LS Polaris Innovation Fund
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $88,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The LS Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early stage academic research. By partnering with passionate entrepreneurs with transformational
| Company | Date | Round | Raised |
|---|---|---|---|
 QurAlis |
March, 10 ,2023 | Series B | $88,000,000 |
 Larkspur Biosciences |
May, 24 ,2023 | Unknown | $35,500,000 |
 Delphia Therapeutics |
May, 07 ,2024 | Series A | $67,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
